Press Release Archive

11.15.2010

Pfizer Launches New Advil® Congestion Relief and Offers 100 Holiday Shoppers Literal Decongestion From Black Friday Crowds

11.13.2010

Adding INSPRA® (eplerenone) to Standard Therapy Significantly Reduces the Risk of CV Mortality and Morbidity in Patients With Chronic Heart Failure With Mild Symptoms, Study Shows

11.09.2010

Lower Protein in Infant Formula Supports Growth Rate Similar to Breast Milk, New Study Shows

11.08.2010

Alpine Mountaineer and Alzheimer's Advocate to Climb Highest Peak on Each Continent to Raise Awareness of Growing Prevalence and Burden of Alzheimer's Disease

11.07.2010

In First Phase 3 Trial, Tasocitinib (CP-690,550), an Oral JAK Inhibitor, Administered as Monotherapy, Reduces Signs and Symptoms of Active Rheumatoid Arthritis and Improves Physical Function

11.03.2010

Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference

11.01.2010

Pfizer Reports Third-Quarter 2010 Results

10.28.2010

Pfizer's Lyrica® (Pregabalin) Capsules CV Receives Approval for Treatment of Peripheral Neuropathic Pain In Japan

10.28.2010

Pfizer Declares an 18-Cent Fourth-Quarter 2010 Dividend

10.27.2010

Results From an Expanded Cohort Phase 1 Study Published in the New England Journal of Medicine Demonstrate a Majority of Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer Responded to Crizotinib (PF-02341066)

10.21.2010

Pfizer Commences Tender Offer for All Outstanding Shares of King Pharmaceuticals, Inc.

10.20.2010

New Phase 4 Study Shows Higher Rates of Clinical and Microbiological Success for Zyvox Versus Vancomycin in MRSA Nosocomial Pneumonia